Clarity Pharmaceuticals Ltd (ASX:CU6)

Clarity Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	57.21	47.68	47.9	31.21	55.34
Short-Term Investments	121.05	36.43	88.6	33.8	37
Cash & Short-Term Investments	178.25	84.12	136.51	65.01	92.34
Cash Growth	111.91%	-38.38%	109.96%	-29.59%	387.54%
Other Receivables	12.82	10.1	12.63	10	6.66
Receivables	12.82	10.1	12.63	10	6.66
Prepaid Expenses	7.32	6.33	4.83	1.66	0.56
Other Current Assets	0.09	0.06	0.09	-	-
Total Current Assets	198.49	100.61	154.06	76.68	99.55
Property, Plant & Equipment	0.57	0.55	0.55	0.21	0.26
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01
Total Assets	199.06	101.17	154.63	76.9	99.82

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	3.62	3.21	2.08	2.85	2.85
Accrued Expenses	5.93	4.36	2.7	1.84	4.16
Current Income Taxes Payable	0.09	-	0.21	-	-
Other Current Liabilities	2.7	2.82	3.09	2.85	0.49
Total Current Liabilities	12.34	10.38	8.09	7.54	7.51
Other Long-Term Liabilities	0.62	0.56	0.24	0.18	0.08
Total Liabilities	12.96	10.94	8.33	7.72	7.59

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	450.96	255.89	262.4	132.82	132.12
Retained Earnings	-284.12	-176.99	-112.7	-70.37	-45.8
Comprehensive Income & Other	19.27	11.34	-3.4	6.73	5.92
Shareholders' Equity	186.11	90.23	146.3	69.18	92.24
Total Liabilities & Equity	199.06	101.17	154.63	76.9	99.82

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Cash (Debt)	178.25	84.12	136.51	65.01	92.34
Net Cash Growth	111.91%	-38.38%	109.96%	-29.59%	387.54%
Net Cash Per Share	0.48	0.26	0.50	0.25	0.37
Filing Date Shares Outstanding	372.97	321.47	311.65	260.66	257.94
Total Common Shares Outstanding	372.97	321.47	311.65	260.66	257.94
Working Capital	186.15	90.23	145.97	69.14	92.04
Book Value Per Share	0.50	0.28	0.47	0.27	0.36
Tangible Book Value	186.11	90.23	146.3	69.18	92.24
Tangible Book Value Per Share	0.50	0.28	0.47	0.27	0.36
Machinery	-	-	0.93	0.44	0.39

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error